Atlas Venture
Capital Type
Venture Capital
Investment Size
Undisclosed / varies by deal
Geographic Scope
US, Europe
Return Model
Dilutive
Stage Focus
Seed, Company creation, Early-stage
Modality Focus
Therapeutics, Platform biotech
Overview
Company-creation biotech VC with deep scientific involvement at formation stage.
Portfolio and Signals
Relevant for AMR founders because it can support technically ambitious therapeutic or platform companies from inception, even if the firm is not AMR-specific.
Access and Engagement
Best approached through syndicate relationships, entrepreneurs-in-residence, and top-tier scientific validation.
Notable AMR Examples / Programs
Company-creation model suited to science-first startups
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
